nicotinamide mononucleotide has been researched along with Degenerative Diseases, Central Nervous System in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Braidy, N; Helman, T | 1 |
| Gu, J; He, W; He, Y; Kong, M; Mao, Y; Wang, Y; Xu, H; Zhao, X | 1 |
| Borén, J; Doganay, HL; Jin, H; Li, X; Mardinoglu, A; Nielsen, J; Ozturk, G; Turkez, H; Uhlén, M; Yang, H; Zhang, C | 1 |
| Braidy, N; Liu, Y | 1 |
| Klimova, N; Kristian, T | 1 |
| Fishman, PS; Kristian, T; Long, AN; Owens, K; Schlappal, AE; Schuh, RA | 1 |
3 review(s) available for nicotinamide mononucleotide and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders.
Topics: Aging; Dietary Supplements; Humans; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide | 2023 |
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.
Topics: Aging; Animals; Humans; Inflammation; Mice; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide; Oxidative Stress; Pyridinium Compounds; Rats; Risk Assessment | 2020 |
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.
Topics: Animals; Brain; Humans; Hydrolases; Mitochondria; NAD; Neurodegenerative Diseases; Niacinamide; Nicotinamide Mononucleotide | 2019 |
1 trial(s) available for nicotinamide mononucleotide and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The acute effect of different NAD
Topics: Humans; Metabolic Diseases; NAD; Neurodegenerative Diseases; Niacin; Niacinamide; Nicotinamide Mononucleotide | 2023 |
2 other study(ies) available for nicotinamide mononucleotide and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Nicotinamide mononucleotide improves the Alzheimer's disease by regulating intestinal microbiota.
Topics: Alzheimer Disease; Animals; Brain; Gastrointestinal Microbiome; Mice; Neurodegenerative Diseases; Nicotinamide Mononucleotide | 2023 |
Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
Topics: Alzheimer Disease; Animals; Brain; Female; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Nicotinamide Mononucleotide; Oxygen Consumption | 2015 |